| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Movement Disorders Clinical Practice |
| Jahrgang | 5 |
| Ausgabenummer | 5 |
| Seiten (von - bis) | 548-550 |
| Seitenumfang | 3 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 01.09.2018 |
Fördermittel
Ethical Compliance Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written consent to publish all shown materials was obtained from the patient in Serbian. Funding Sources and Conflicts of Interest: This study was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia, project no. 175090 (to VK). The authors report no conflicts of interest. Financial Disclosures for previous 12 months: Nikola Kresojevi? is a member of advisory board of Univar BV. Igor Petrovi? has received speaker honoraria from Boehringer Ingelheim, GSK, El Pharma, Roche, and Actavis. Valerija Dobri?i?, Aleksandra Tomi?, Vesna Brankovi? and Vedrana Mili? Ra?i?: report no sources of funding and no conflicts of interest. Marina Svetel has received speaker's honoraria from Actavis. Vladimir Kosti? has received research grants from the Ministry of Education, Science, and Technological Development, Republic of Serbia and the Serbian Academy of Science and Arts; and speaker honoraria from Actavis and Salveo. Funding Sources and Conflicts of Interest: This study was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia, project no. 175090 (to VK). The authors report no conflicts of interest. Financial Disclosures for previous 12 months: Nikola Kresojevićis a member of advisory board of Univar BV. Igor Pet-rovićhas received speaker honoraria from Boehringer Ingelheim, GSK, El Pharma, Roche, and Actavis. Valerija Dobri≤cić, Aleksandra Tomić, Vesna Brankovićand Vedrana MilićRašić: report no sources of funding and no conflicts of interest. Marina Svetel has received speaker’s honoraria from Actavis. Vladimir Kostićhas received research grants from the Ministry of Education, Science, and Technological Development, Republic of Serbia and the Serbian Academy of Science and Arts; and speaker honoraria from Actavis and Salveo.
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
